Spatial composition of prostate cancer spheroids in mixed and static cultures

Tissue Engineering

Volumn 10, Issue 7-8, 2004, Pages 1266-1276

  Song, Hong ^a,b,c   David, Odile ^b,d   Clejan, Sanda ^b,d   Giordano, Carrie L ^a,e   Pappas Lebeau, Helena ^b   Xu, Li ^a   O'Connor, Kim C ^a,b,d,f  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f Tulane University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P;

ANIMAL CELL; CELL AGGREGATION; CELL COMPOSITION; CELL DEATH; CELL DENSITY; CELL DIFFERENTIATION; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RABBIT; TUMOR CELL CULTURE; TUMOR SPHEROID;

NASA DISCIPLINE CELL BIOTECHNOLOGY; NON-NASA CENTER;

CELL LINE, TUMOR; COCULTURE TECHNIQUES; HUMANS; MALE; PROSTATIC NEOPLASMS; SPHEROIDS, CELLULAR; TISSUE ENGINEERING;

EID: 4544231619     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2004.10.1266     Document Type: Conference Paper

References (32)

1. O'Connor, K.C. Three-dimensional cultures of prostatic cells: Tissue models for the development of novel anti-cancer therapies. Pharm. Res. 16, 486, 1999.
2. Desoize, B., Gimonet, D., and Jardiller, J.-C. Cell culture as spheroids: An approach to multicellular resistance. Anticancer Res. 18, 4147, 1998.
3. Kitahara, M., Katakura, R., Suzuki, J., and Sasaki, T. Experimental combination chemotherapy of ACNU and 5-FU against cultured glioma model (spheroid) and subcutaneous rat glioma. Int. J. Cancer 40, 557, 1987.
4. Alpaugh, M.L., and Barsky, S.H. Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo. Hum. Gene Ther. 13, 1245, 2002.
5. Wenning, L.A., and Murphy, R.M. Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids. Biotechnol. Bioeng. 62, 562, 1999.
6. Sutherland, R.M. Cell and environment interactions in tumor microregions: The multicell spheroid model. Science 240, 177, 1988.
7. Jessup, J.M., Frantz, M., Sonmez-Alpan, E., Locker, J., Skena, K., Waller, H., Battle, P., Nachman, A., Weber, M.E., Thomas, D.A., Curbeam, R.L., Baker, T.L., and Goodwin, T.J. Microgravity culture reduces apoptosis and increases the differentiation of a human colorectal carcinoma cell line. In Vitro Cell. Dev. Biol. Anim. 36, 367, 2000.
8. Gooch, K.J., Kwon, J.H., Blunk, T., Langer, R., Freed, L.E., and Vunjak-Novakovic, G. Effects of mixing intensity on tissue-engineered cartilage. Biotechnol. Bioeng. 72, 402, 2001.
9. Sikavitsas, V.I., Bancroft, G.N., and Mikos A.G. Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J. Biomed. Mater. Res. 62, 136, 2002.
10. Jain, R.K. Delivery of molecular and cellular medicine to solid tumors. J. Control. Release 53, 49, 1998.
11. Jemal, A., Thomas, A., Murray, T., and Thun, M., Cancer statistics. CA Cancer J. Clin. 52, 181, 2002.
12. van Brussel, J.P., van Steenbrugge, G.J., van Krimpen, C., Bogdanowicz, J.F.A.T., van der Kwast, T.H., Schröder, F.H., and Mickisch, G.H.J. Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer. J. Urol. 165, 130, 2001.
13. Sullivan, G.F., Amenta, P.S., Villanueva, J.D., Alvarez, C.J., Yang, J.-M., and Hait, W.N. The expression of drug resistance gene products during the progression of human prostate cancer. Clin. Cancer Res. 4, 1393, 1998.
14. Dahiya, R., Boyle, B., Goldberg, B.C., Yoon, W.-H., Konety, B., Chen, K., Yen, T.-S.B., Blumenfeld, W., and Narayan, P. Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines. Biochem. Cell Biol. 70, 548, 1992.
15. Horoszewicz, J.S., Leong, S.S., Kawinski, E., Karr, J.P., Rosenthal, H., Chu, T.M., Mirand, E.A., and Murphy, G.P. LNCaP model of human prostatic carcinoma. Cancer Res. 43, 1809, 1983.
16. Lelkes, P.I., Ramos, E., Nikolaychik, V.V., Wankowski, D.M., Unsworth, B.R., and Goodwin, T.J. GTSF-2: A new, versatile cell culture medium for diverse normal and transformed mammalian cells. In Vitro Cell. Dev. Biol. Anim. 33, 344, 1997.
17. Enmon, R.M., O'Connor, K.C., Song, H., Lacks, D.J., and Schwartz, D.K. Aggregation kinetics of well and poorly differentiated human prostate cancer cells. Biotechnol. Bioeng. 80, 580, 2002.
18. Clejan, S., O'Connor, K.C., Cowger, N.L., Cheles, M.K., Haque, S., and Primavera, A.C. Effects of simulated microgravity on DU 145 human prostate carcinoma cells. Biotechnol. Bioeng. 50, 587, 1996.
19. Yu, C.C.-W., Woods, A.L., and Levison, D.A. The assessment of cellular proliferation by immunohistochemistry: A review of currently available methods and their applications. Histochem. J. 24, 121, 1992.
20. Wartenberg, M., Fischer, K., Hescheler, J., and Sauer, H. Modulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by cell cycle inhibitors. Biochim. Biophys. Acta 1589, 49, 2002.
21. Zhan, Q.M., Jin, S.Q., Ng, B., Plisket, J., Shangary, S., Rathi, A., Brown, K.D., and Baskaran, R. Caspase-3 mediated cleavage of BRCA1 during UV-induced apoptosis. Oncogene 21, 5335, 2002.
22. Hrycyna, C.A. Molecular genetic analysis and biochemical characterization of mammalian P-glycoproteins involved in multidrug resistance. Semin. Cell Dev. Biol. 12, 247, 2001.
23. Borst, P., Evers, R., Kool, M., and Wijnholds, J. A family of drug transporters: The multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92, 1295, 2000.
24. van Brussel, J.P., van Steenbrugge, G.J., Romijn, J.C., Schröder, F.H., and Mickisch, G.H.J. Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins. Eur. J. Cancer 35, 664, 1999.
25. Bird, R.B., Stewart, W.E., and Lightfoot, E.N. Transport Phenomena. New York: John Wiley & Sons, 1960.
26. Netti, P.A., Berk, D.A., Swartz, M.A., Grodzinsky, A.J., and Jain, R.K. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 60, 2497, 2000.
27. Burns-Cox, N., Avery, N.C., Gingell, J.C., and Bailey, A.J. Changes in collagen metabolism in prostate cancer: A host response that may alter progression. J. Urol. 166, 1698, 2001.
28. Slater, M.D., Lauer, C., Gidley-Baird, A., and Barden, J.A. Markers for the development of early prostate cancer. J. Pathol. 199, 368, 2003.
29. Cheng, L., Nagabhushan, M., Pretlow, T.P., Amini, S.B., and Pretlow, T.G. Expression of E-cadherin in primary and metastatic prostate cancer. Am. J. Pathol. 148, 1375, 1996.
30. Wartenberg, M., Frey, C., Diedershagen, H., Ritgen, J., Hescheler, J., and Sauer, H. Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids. Int. J. Cancer 75, 855, 1998.
31. Wartenberg, M., Dönmez, F., Ling, F.C., Acker, H., Hescheler, J., and Sauer, H. Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells. FASEB J. 15, 995, 2001.
32. Comerford, K.M., Wallace, T.J., Karhausen, J., Louis, N.A., Montalto, M.C., and Colgan, S.P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62, 3387, 2002.